Pinealon 10mg is a specialized synthetic peptide bioregulator designed for rigorous scientific inquiry into neuroprotection and cellular communication within the central nervous system. Developed for researchers investigating biological age-reversal and cognitive health models, this 10mg vial provides a stable medium for exploring the restoration of protein synthesis in neuronal tissues. Every batch is synthesized to meet high analytical standards, ensuring the consistency required for tracking gene expression and physiological responses in advanced laboratory settings.
n
nFor Research Use Only (RUO). Not for human or animal use.
n
n
n
n
Overview
nPinealon 10mg is a short-chain synthetic peptide bioregulator frequently utilized in preclinical and analytical literature to investigate neuro-regulatory pathways, cellular aging, and protein synthesis within specialized biochemical frameworks. This 10mg formulation is engineered specifically for laboratory environments requiring precision in dosage, peptide characterization, and rigorous experimental oversight.
n
nOngoing scientific inquiry into Pinealon focuses on non-clinical environments, where researchers examine its role in modulating gene expression within neuronal tissues and its influence on signaling cascades related to oxidative stress and circadian rhythm regulation. In established in vitro and in vivo models, investigators utilize this compound to analyze its interaction with DNA structures, its impact on cellular longevity, and the structural integrity of the peptide under varied experimental parameters.
n
nAll data and observations associated with this compound are strictly limited to laboratory-based scientific investigation. No assertions are made concerning therapeutic potential, clinical efficacy, physiological impact, or safety for human or veterinary applications.
n
n
n
n
Biochemical Characteristics
nPinealon 10mg is a synthetic research peptide bioregulator extensively documented in scientific literature regarding neuro-regulatory pathways, gene expression modulation, and the analysis of cellular protein synthesis. The characterization of this compound is performed solely through rigorous physicochemical testing and controlled laboratory-based research protocols.
n
nBiochemical evaluation of Pinealon typically involves precise identity verification, purity analysis via High-Performance Liquid Chromatography (HPLC), molecular mass confirmation, and stability assessments under standardized storage conditions. In preclinical settings, researchers utilize experimental models to investigate the peptide’s interaction with targeted DNA sequences, its influence on intracellular signaling cascades in neuronal tissues, and its molecular behavior within aging and longevity frameworks. These studies are conducted exclusively using structured in vitro systems and controlled experimental environments dedicated to advanced scientific inquiry.
n
nAll technical documentation and data relating to this compound are confined to investigational and non-clinical laboratory contexts. No claims are made regarding therapeutic potential, clinical use, physiological outcomes, or safety for human or veterinary applications.
n
-
- n
- Molecular Class: Synthetic peptide bioregulator (Tripeptide)
n
-
- Peptide Composition: Glu-Asp-Arg (EDR)
n
-
- Purity: Research-grade, high-purity peptide material
n
-
- Material State: Lyophilized peptide powder
n
-
- Quantity: 10mg per vial
n
-
- Intended Use: Laboratory research only
n
n
n
n
n
Research Applications
nWithin scientific and preclinical literature, Pinealon 10mg is identified as a synthetic research peptide evaluated exclusively in controlled, non-clinical laboratory environments. Its application is strictly limited to analytical investigation, gene expression studies, and neuro-regulatory pathway modeling conducted under rigorous experimental protocols.
n
nDocumented laboratory research contexts for this bioregulator variant may include:
n
-
- n
- Neuro-Regulatory Pathway Modeling: Examining the peptide’s influence on the central nervous system and the regulation of circadian rhythms within controlled cellular systems.
n
-
- Gene Expression & Protein Synthesis Analysis: Focusing on the interaction of the EDR sequence with DNA structures to evaluate its role in modulating protein synthesis in neuronal tissues.
n
-
- Oxidative Stress & Cytoprotection Studies: Utilizing experimental models designed to assess cellular resilience against oxidative damage and environmental stressors in regulated laboratory settings.
n
-
- Stability and Structural Integrity Testing: Assessing peptide resilience following reconstitution and throughout varied storage and handling conditions in the lab.
n
-
- Bioregulatory Kinetic Evaluation: Exploring the structural and functional relationships between short-chain peptides and long-term cellular homeostasis within broader biochemical frameworks.
n
-
- Analytical Benchmarking: Procedures utilizing validated reference standards, mass spectrometry, and chromatographic verification for laboratory quality control assessments.
n
nAll referenced applications remain strictly confined to laboratory-based investigation and non-clinical experimental use. No statements are made regarding biological outcomes, therapeutic use, clinical relevance, or applicability beyond structured research settings.
n
n
n
n
Pathway / Mechanistic Context
nIn experimental and preclinical research literature, Pinealon 10mg is referenced in relation to peptide bioregulation frameworks and DNA-interaction pathways examined at the molecular and biochemical level. These investigations are conducted strictly within controlled laboratory environments to support the structured analysis of peptide-driven signaling activity, protein interaction dynamics, and gene expression modulation under defined experimental conditions.
n
nScientific discussion surrounding Pinealon often emphasizes its role as a short-chain peptide capable of penetrating cellular and nuclear membranes to interact directly with chromatin. Within laboratory research systems, mechanistic evaluation may include:
n
-
- n
- Epigenetic Modulation Analysis: Investigating the interaction between the EDR tripeptide and specific DNA sequences to understand its role in regulating the transcription of genes associated with neuronal health.
n
-
- Protein Synthesis Regulation: Observation of ribosomal activity and the subsequent synthesis of structural and functional proteins within controlled neuronal cellular environments.
n
-
- Circadian Rhythm Pathways: Examination of the molecular changes in the pineal gland and the expression of genes associated with melatonin production and sleep-wake cycle homeostasis.
n
-
- Neuroprotective Signaling Mapping: Identifying downstream regulatory pathways associated with the reduction of pro-inflammatory cytokines and the preservation of synaptic plasticity under controlled in vitro conditions.
n
-
- Telomere and Longevity Modeling: Assessing the influence of peptide-DNA coupling on cellular senescence markers and telomerase activity in specialized laboratory frameworks.
n
nAll mechanistic interpretations remain observational and exploratory in nature and are confined exclusively to non-clinical research settings. No representations extend beyond controlled experimental frameworks, and no claims are made regarding biological outcomes, clinical relevance, or applicability outside structured investigational use.
n
n
n
n
Preclinical Research Summary
nPreclinical research literature references observational findings related to Pinealon 10mg derived from controlled experimental systems designed to evaluate peptide-DNA interaction dynamics within non-clinical research frameworks. These investigations focus on laboratory-based analysis of peptide identity verification, gene-regulatory behavior—particularly the modulation of neuronal protein synthesis—molecular stability profiling, and signaling pathway activity under defined analytical conditions.
n
nExploratory research discussions involving this 10mg concentration commonly include evaluation within neuro-regulatory signaling models and cellular homeostasis communication systems examined in structured laboratory environments. Additional analyses may include:
n
-
- n
- Stability Profiling: Assessment of peptide stability under varying storage conditions and across extended experimental timelines.
n
-
- Structural Integrity: Verification of the EDR tripeptide composition following reconstitution in various laboratory media.
n
-
- Pathway Mapping: Identifying interaction patterns within neuro-protective and circadian rhythm regulatory pathways.
n
-
- Intracellular Observation: Monitoring downstream molecular responses, such as changes in chromatin accessibility and transcription factor activation, within regulated in vitro and preclinical experimental systems.
n
nAll documented observations remain confined to investigational, analytical, and preclinical laboratory contexts and are presented solely for exploratory scientific research purposes. No findings imply clinical relevance, therapeutic application, physiological effects, or suitability for human or veterinary use. All references are limited exclusively to controlled laboratory research environments.
n
n
n
n
Form & Analytical Testing
nPinealon 10mg is supplied as a research-grade synthetic peptide produced under rigorous manufacturing standards to ensure batch consistency, precise identity verification, and high-purity specifications essential for advanced laboratory analysis. This compound is provided in a lyophilized peptide powder form, which supports long-term stability and standardized preparation protocols within structured analytical and experimental research workflows.
n
nMaterial verification for this 10mg format centers on physicochemical characterization and quality parameters critical to peptide identity and neuro-regulatory interaction study. Analytical evaluation typically includes:
n
-
- n
- Identity Confirmation: Verification of the EDR (Glu-Asp-Arg) tripeptide sequence and specific bioregulator structural configuration.
n
-
- Purity Assessment: Utilization of validated chromatographic techniques, such as High-Performance Liquid Chromatography (HPLC), to ensure research-grade quality.
n
-
- Batch Consistency: Systematic verification to ensure uniformity across different production lots for reproducible research data.
n
-
- Molecular Mass Determination: Confirmation of chemical composition and molecular weight via mass spectrometry.
n
-
- Stability Testing: Evaluation of the material under defined laboratory storage and handling conditions to maintain experimental integrity and bioactivity post-reconstitution.
n
nAll testing, validation, and quality control procedures are conducted exclusively to support material characterization within controlled, non-clinical laboratory research environments.
n
n
n
n
Referenced Citations
n
-
- n
- Khavinson, V. K., et al. (2014). Short Peptides Regulate Gene Expression. Bulletin of Experimental Biology and Medicine, 157(1), 87–91.
n
-
- Khavinson, V. K., et al. (2020). Peptide Regulation of Aging. Gerontology, 66(3), 266–274.
n
-
- Mendzheritskii, A. M., et al. (2015). Neuroprotective Effects of the Pinealon Peptide in Brain Ischemia. Neuroscience and Behavioral Physiology, 45(5), 581–584.
n
-
- Khavinson, V. K., & Morozov, V. G. (2003). Peptides of Pineal Gland and Thymus in Regulation of Ageing. Annals of the New York Academy of Sciences, 1001(1), 1–34.
n
-
- Linkova, N. S., et al. (2016). Peptide Pinealon: Effects on the Functions of the Nervous System in Aging. Advances in Gerontology, 6(3), 195–200.
n
-
- Anisimov, V. N., & Khavinson, V. K. (2010). Peptide Bioregulators in the Prevention of Age-Associated Pathology. Russian Journal of Bioorganic Chemistry, 36(3), 273–280.
n
-
- Khavinson, V. K., et al. (2011). Short Peptides as Potent Antineoplastic Agents. Anti-Cancer Agents in Medicinal Chemistry, 11(1), 31–39.
n
-
- Tsygan, N. V., et al. (2017). Neuroprotective Effects of Pinealon in the Modeling of Neurodegenerative Processes. Journal of Evolutionary Biochemistry and Physiology, 53(4), 288–294.
n
-
- Khavinson, V. K., & Malinin, V. V. (2005). Gerontological Aspects of Genome Peptide Regulation. Human Physiology, 31(1), 105–111.
n
nALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. FOR RESEARCH USE ONLY (RUO). NOT FOR HUMAN OR VETERINARY USE.
n
n
n
n
RUO Disclaimer
nAll products offered on this website, including Pinealon 10mg, are intended strictly for in vitro laboratory research purposes only. In vitro research refers to experimental procedures conducted outside of living organisms within controlled laboratory environments for analytical and investigative study.
n
nThese materials are not classified as drugs, pharmaceuticals, dietary supplements, or medical products. They have not been reviewed, evaluated, or approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, cure, or prevention of any disease or medical condition. Any use outside of structured laboratory research—including administration to humans or animals—is strictly prohibited.
n
nFor Laboratory Research Use Only (RUO). Not for human use, medical use, diagnostic use, or veterinary use.
Reviews
There are no reviews yet.